Casdin Capital’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
2018
Q3
$3.84M Hold
2018
Q2
$4.74M Hold
2018
Q1
$5.9M Buy
2017
Q4
$3.75M Hold
2017
Q3
$3.23M Hold
2017
Q2
$2.75M Hold
2017
Q1
$3.06M Buy
2016
Q4
$1.4M Hold
2016
Q3
$2M Sell
2016
Q2
$2.39M Sell
2016
Q1
$4.14M Hold
2015
Q4
$6.7M Buy